Penumbra, Inc. (PEN)
322.19
+1.05
(+0.33%)
USD |
NYSE |
Sep 04, 16:00
322.19
0.00 (0.00%)
After-Hours: 20:00
Penumbra Cash and Short Term Investments (Annual) : 544.82M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 544.82M |
| December 31, 2024 | 340.13M |
| December 31, 2023 | 289.19M |
| December 31, 2022 | 188.03M |
| December 31, 2021 | 254.88M |
| December 31, 2020 | 264.83M |
| December 31, 2019 | 189.39M |
| Date | Value |
|---|---|
| December 31, 2018 | 200.89M |
| December 31, 2017 | 214.59M |
| December 31, 2016 | 128.75M |
| December 31, 2015 | 148.80M |
| December 31, 2014 | 51.54M |
| December 31, 2013 | 13.68M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Boston Scientific Corp. | 2.045B |
| Globus Medical, Inc. | 557.24M |
| Teleflex, Inc. | 393.26M |
| Abbott Laboratories | 8.939B |
| AngioDynamics, Inc. | 53.86M |